l glutathione reduced pharmacology The Role of Metabolism in Chronic Illness Development and Its Potential Use as a Novel Therapeutic Target Frontiers | Glutathione and mitochondria
Description
For all other applications, SS-31 remains an investigational compound
In DCM, lysosomal dysfunction is commonly observed, including increased membrane permeability, a decreased number of acidic lysosomes, and impaired autophagosomelysosome fusion efficiency (Figure 4)
Side effect profiles are similar in type (GI effects dominate both) but different in severity
Lipopolysaccharide induced increase in seizure activity in two animal models of absence epilepsy WAG/Rij and GAERS rats and Long Evans rats
